Blog

“Good morning, Rob! Based on your recent runs, it looks like you’re due for a fresh pair of sneakers. A new trail runner just dropped in size 10.5, built for the terrain you love. As a loyalty member, we’ve reserved a pair at your local store. Stop by this weekend to enjoy early access.”

Attending the Databricks Data + AI Summit 2025 in San Francisco was nothing short of inspiring for me and the Nandika Techno Analytics team. The energy in the room, the innovation on display, and the conversations we had with peers and leaders all pointed to one thing: AI is no longer experimental, it’s becoming foundational.

As AI products become more responsible and explainable, AI-Augmented leaders need persona-specific experiences for meaningful conversations with AI.

Artificial Intelligence (AI) has become a strategic cornerstone in modern enterprises. A new leadership paradigm is emerging—AI-Augmented Leaders—executives who rely on intelligent systems not only for support but also for critical decision-making. With 38% of executives now trusting AI to make business decisions, the conversation has shifted from experimentation to integration.

Nandika Techno Analytics Pharma AI Insights Series

AI is no longer an experimental tool in healthcare — it is actively reshaping how pharmaceutical companies work, compete, and care. Leaders like Bayer, Medtronic, and AstraZeneca are already advancing on IMD’s AI Maturity Index, using AI not only for drug discovery but also for listening, learning, and leading with empathy.

Nandika Techno Analytics Pharma AI Insights Series

In today’s fast-evolving healthcare landscape, 40% of interactions with healthcare professionals (HCPs) miss the mark—delivering the wrong message, at the wrong time, through the wrong channel. For pharmaceutical and MedTech companies, these missed opportunities translate into $2–3 billion in lost sales annually.